Claudia Barbosa Assunção

Claudia Barbosa Assunção

Auto-generated profile, based on publicly available information

Claudia Barbosa Assunção

Hospital Santa Casa de Belo Horizonte, Brasil

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Medical Mycology Case Reports
Verified
Journal Article
Open access
FRFabiana Rocha-Silva
Fabiana Rocha-Silva
SFSônia M. Figueiredo
Sônia M. Figueiredo
TSThamara T.S. Silveira
Thamara T.S. Silveira
CAClaudia B. Assunção
Claudia B. Assunção
SCSabrina S. Campolina
Sabrina S. Campolina
RCRachel B. Caligiorne
Rachel B. Caligiorne
In this study, we report four cases of Histoplasma capsulatum infection in eight biologists who made an expedition to determine the prevalence of this fungus in a cave localized in the northwest of Minas Gerais state, Brazil. This case report demonstrates the importance of evaluating the H. capsulatum presence in Brazilian caves before opening to public visitations.

1 January 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
FMFabrício Moreira Monteiro
Fabrício Moreira Monteiro
AMAmanda Sanchez Machado
Amanda Sanchez Machado
FRFabiana Rocha-Silva
Fabiana Rocha-Silva
CACláudia Barbosa Assunção
Cláudia Barbosa Assunção
CGCidiane Graciele-Melo
Cidiane Graciele-Melo
RCRachel Basques Caligiorne
Rachel Basques Caligiorne

1 September 2018 in Medical Mycology Case Reports
Verified
Journal Article
Open access
BFBlenda Fernandes
Blenda Fernandes
RCRachel Basques Caligiorne
Rachel Basques Caligiorne
DCDayana Monteiro Coutinho
Dayana Monteiro Coutinho
RGRenata R. Gomes
Renata R. Gomes
FRFabiana Rocha-Silva
Fabiana Rocha-Silva
SHSybren de Hoog
Sybren de Hoog
This paper presents a case of disseminated sporotrichosis in a 13-year-old female, originating from a rural area in Minas Gerais state, Brazil. The patient was hospitalized in Santa Casa hospital of Belo Horizonte, with hyporexia, prostration, fever and disseminated ulcerative lesions, besides anemia, leucopenia and sepsis of probable cutaneous focus. The patient was admitted without proven immunosuppression. She was diagnosed with cutaneous-disseminated sporotrichosis. The drug therapy chosen was itraconazole during 12 months, leading to important clinical improvement and healing of cutaneous lesions.

1 August 2018 in Microbial Pathogenesis
Verified
Journal Article
Closed access
FRFabiana Rocha-Silva
Fabiana Rocha-Silva
SFSônia Maria Figueiredo
Sônia Maria Figueiredo
ESEmanoelle Fernandes Rutren La Santrer
Emanoelle Fernandes Rutren La Santrer
AMAmanda Sanchez Machado
Amanda Sanchez Machado
BFBlenda Fernandes
Blenda Fernandes
RCRachel Basques Caligiorne
Rachel Basques Caligiorne

12 September 2017 in Infectious Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
MTMarcia M. R. Teixeira
Marcia M. R. Teixeira
CAClaudia B. Assuncao
Claudia B. Assuncao
SLSandra Lyon
Sandra Lyon
RGRenata R. Gomes
Renata R. Gomes
HJHyllo B.M. Junior
Hyllo B.M. Junior
RCRachel B. Caligiorne
Rachel B. Caligiorne
Subcutaneous phaeohyphomycosis is a form of infection caused by dematiaceous fungi and frequently reported in the literature. It is considered as an emerging mycosis because it is increasingly reported among immunosuppressive patients. The most commonly cited etiologic agent is Exophiala jeanselmei, followed by Alternaria spp. We present a case of a 48-year-old woman, with a history of lepromatous leprosy, using corticosteroid in immunosuppressive doses due to a type 2 repetitive reaction leprosy outbreak, revealing subcutaneous phaeohyphomycosis lesions. The diagnosis was confirmed by fine-needle aspiration of the secretion, with subsequent molecular analysis, and culture and direct mycological analyses.

25 January 2020 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
AMA S Machado
A S Machado
SLS Lyon
S Lyon
FSFabiana Rocha Silva
Fabiana Rocha Silva
CAC B Assunção
C B Assunção
MHM N Hernandez
M N Hernandez
RCR B Caligiorne
R B Caligiorne
Aims Diagnosis of leprosy, a chronic infection caused by Mycobacterium leprae, predominantly depends on clinical manifestations and histopathological analysis, hampering rapid and accurate diagnostics. Our aim was to increase accuracy of leprosy diagnosis by improving M. leprae’s DNA detection based on Polimerase chain reaction (PCR) technique using new specific primers for the RLEP repetitive sequence. Methods and Results The specific target region, RLEP, of M. leprae’s genome was selected based on comparative genomics. After confirming the specificity of this region, using BlastN analysis, primers were designed and tested for their in silico specificity. To evaluate the specificity and sensitivity of these primers in vitro, 184 blood samples from patients were used in qPCR. The new primer pair LYON1/LYON2 produced 91% positive samples, while the current primer pair LP1/LP2 produced 46%. Specificity and DNA detection limit test were carry out to compare the efficiency of the developed primer pair. The LYON1/LYON2 primer showed 100% specificity, while LP1/LP2 showed 64%. The DNA detection limit of LYON1/LYON2 was 10 copies of bacterial genomes per milliliter, while LP1/LP2 was 1,000 copies of bacterial genomes per milliliter. Conclusions In conclusion, the developed LYON1/LYON2 primer pair presented to be a specific and sensitive new molecular marker for the diagnosis of leprosy. Significance and Impact of the Study The development of a specific primer pair for the detection of the M. leprae genome through qPCR technique contributes to a fast, sensitive and specific diagnosis, which is essential to prevent spreading and progression of this disease.